Skip to content

Clinical trials

Recruiting Phase 1 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Recruiting Country / region: South Korea Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20203
20218
202210
202313
202432
202544
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting145

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daewoong Pharmaceutical Co. LTD.6
Eli Lilly and Company6
BeOne Medicines5
Addpharma Inc.4
Amgen4
AstraZeneca4
Boryung Pharmaceutical Co., Ltd4
Genentech, Inc.4
AbbVie3
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung17
Neoplasms12
Neoplasm Metastasis11
Colorectal Neoplasms9
Carcinoma, Hepatocellular7
Ovarian Neoplasms7
Recurrence7
Stomach Neoplasms7
Triple Negative Breast Neoplasms7
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.